Literature DB >> 18350606

Genome-wide differences in hepatitis C- vs alcoholism-associated hepatocellular carcinoma.

Celine Derambure1, Cedric Coulouarn, Frederique Caillot, Romain Daveau, Martine Hiron, Michel Scotte, Arnaud Francois, Celia Duclos, Odile Goria, Marie Gueudin, Catherine Cavard, Benoit Terris, Maryvonne Daveau, Jean-Philippe Salier.   

Abstract

AIM: To look at a comprehensive picture of etiology-dependent gene abnormalities in hepatocellular carcinoma in Western Europe.
METHODS: With a liver-oriented microarray, transcript levels were compared in nodules and cirrhosis from a training set of patients with hepatocellular carcinoma (alcoholism, 12; hepatitis C, 10) and 5 controls. Loose or tight selection of informative transcripts with an abnormal abundance was statistically valid and the tightly selected transcripts were next quantified by qRTPCR in the nodules from our training set (12 + 10) and a test set (6 + 7).
RESULTS: A selection of 475 transcripts pointed to significant gene over-representation on chromosome 8 (alcoholism) or -2 (hepatitis C) and ontology indicated a predominant inflammatory response (alcoholism) or changes in cell cycle regulation, transcription factors and interferon responsiveness (hepatitis C). A stringent selection of 23 transcripts whose differences between etiologies were significant in nodules but not in cirrhotic tissue indicated that the above dysregulations take place in tumor but not in the surrounding cirrhosis. These 23 transcripts separated our test set according to etiologies. The inflammation-associated transcripts pointed to limited alterations of free iron metabolism in alcoholic vs hepatitis C tumors.
CONCLUSION: Etiology-specific abnormalities (chromo-some preference; differences in transcriptomes and related functions) have been identified in hepatocellular carcinoma driven by alcoholism or hepatitis C. This may open novel avenues for differential therapies in this disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18350606      PMCID: PMC2695915          DOI: 10.3748/wjg.14.1749

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  35 in total

1.  Telomere shortening correlates with increasing aneuploidy of chromosome 8 in human hepatocellular carcinoma.

Authors:  Ruben R Plentz; Brigitte Schlegelberger; Peer Flemming; Michael Gebel; Hans Kreipe; Michael P Manns; K Lenhard Rudolph; Ludwig Wilkens
Journal:  Hepatology       Date:  2005-09       Impact factor: 17.425

Review 2.  Genetics of hepatocellular tumors.

Authors:  P Laurent-Puig; J Zucman-Rossi
Journal:  Oncogene       Date:  2006-06-26       Impact factor: 9.867

Review 3.  Molecular prognostication of liver cancer: end of the beginning.

Authors:  Snorri S Thorgeirsson; Ju-Seog Lee; Joe W Grisham
Journal:  J Hepatol       Date:  2006-02-07       Impact factor: 25.083

4.  Differential gene alteration among hepatoma cell lines demonstrated by cDNA microarray-based comparative genomic hybridization.

Authors:  Kazunori Kawaguchi; Masao Honda; Taro Yamashita; Yukihiro Shirota; Shuichi Kaneko
Journal:  Biochem Biophys Res Commun       Date:  2005-04-01       Impact factor: 3.575

5.  Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma.

Authors:  L Xu; L Hui; S Wang; J Gong; Y Jin; Y Wang; Y Ji; X Wu; Z Han; G Hu
Journal:  Cancer Res       Date:  2001-04-01       Impact factor: 12.701

6.  Ethanol metabolism alters interferon gamma signaling in recombinant HepG2 cells.

Authors:  Natalia A Osna; Dahn L Clemens; Terrence M Donohue
Journal:  Hepatology       Date:  2005-11       Impact factor: 17.425

7.  Global gene repression in hepatocellular carcinoma and fetal liver, and suppression of dudulin-2 mRNA as a possible marker for the cirrhosis-to-tumor transition.

Authors:  Cédric Coulouarn; Céline Derambure; Grégory Lefebvre; Romain Daveau; Martine Hiron; Michel Scotte; Arnaud François; Maryvonne Daveau; Jean-Philippe Salier
Journal:  J Hepatol       Date:  2005-04-11       Impact factor: 25.083

8.  Expression of iron regulatory genes in a rat model of hepatocellular carcinoma.

Authors:  Petra Holmström; Mats Gåfvels; Lennart C Eriksson; Vijole Dzikaite; Rolf Hultcrantz; Gösta Eggertsen; Per Stål
Journal:  Liver Int       Date:  2006-10       Impact factor: 5.828

Review 9.  Alcohol and oxidative liver injury.

Authors:  Aparajita Dey; Arthur I Cederbaum
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

10.  Regional copy number-independent deregulation of transcription in cancer.

Authors:  Nicolas Stransky; Céline Vallot; Fabien Reyal; Isabelle Bernard-Pierrot; Sixtina Gil Diez de Medina; Rick Segraves; Yann de Rycke; Paul Elvin; Andrew Cassidy; Carolyn Spraggon; Alexander Graham; Jennifer Southgate; Bernard Asselain; Yves Allory; Claude C Abbou; Donna G Albertson; Jean Paul Thiery; Dominique K Chopin; Daniel Pinkel; François Radvanyi
Journal:  Nat Genet       Date:  2006-11-12       Impact factor: 38.330

View more
  4 in total

1.  Novel serum markers of fibrosis progression for the follow-up of hepatitis C virus-infected patients.

Authors:  Frédérique Caillot; Martine Hiron; Odile Goria; Marie Gueudin; Arnaud Francois; Michel Scotte; Maryvonne Daveau; Jean-Philippe Salier
Journal:  Am J Pathol       Date:  2009-05-28       Impact factor: 4.307

Review 2.  Genetic risk markers for hepatocellular carcinoma in patients with alcoholic liver disease.

Authors:  Pierre Nahon; Angela Sutton; Marianne Ziol; Jessica Zucman-Rossi; Jean-Claude Trinchet; Nathalie Ganne-Carrié
Journal:  Hepat Oncol       Date:  2015-01-12

3.  Transient and etiology-related transcription regulation in cirrhosis prior to hepatocellular carcinoma occurrence.

Authors:  Frederique Caillot; Celine Derambure; Paulette Bioulac-Sage; Arnaud Francois; Michel Scotte; Odile Goria; Martine Hiron; Maryvonne Daveau; Jean Philippe Salier
Journal:  World J Gastroenterol       Date:  2009-01-21       Impact factor: 5.742

4.  Loss of alanine-glyoxylate and serine-pyruvate aminotransferase expression accelerated the progression of hepatocellular carcinoma and predicted poor prognosis.

Authors:  Yufeng Sun; Wenchao Li; Shiqi Shen; Xuejing Yang; Bing Lu; Xiaojing Zhang; Peng Lu; Yi Shen; Juling Ji
Journal:  J Transl Med       Date:  2019-11-26       Impact factor: 5.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.